Side Effects of Ketamine in the Long-Term Treatment of Neuropathic Pain

2008107 citationsJournal Articlebronze Open Access

Authors

Abstract

Ketamine is evaluated as a nonoptimal, however, available NMDA blocker suitable for clinical use. Studying its effects in clinics can be expected to increase our knowledge necessary for the development of new, effective, and safe "antineuralgic drug."

Topics & Keywords

Pain Mechanisms and Treatments Treatment of Major Depression Anesthesia and Pain Management

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Pain Medicine

Volume 9, Issue 2, pp. 253-257

DOI: 10.1111/j.1526-4637.2007.00314.x

Field-Weighted Citation Impact: 5.06